Long-Term RCC Control With Immunotherapy, Despite Early … – Cancer Network
|
Long-Term RCC Control With Immunotherapy, Despite Early …
Cancer Network Immunotherapy offers durable responses lasting more than 6 months after treatment discontinuation for some patients with metastatic renal cell carcinoma. |
